+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition



The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition



American Heart Journal 151(6): 1238.E1



Previous studies provide evidence for a significant reduction of coronary flow reserve after ingestion of meals of different compositions. A possible role of hyperinsulinemia and increased free fatty acid levels, which are deleterious during acute myocardial ischemia and reperfusion, has been hypothesized. We assessed in patients with stable coronary disease the effects of high-fat meals (HFMs) and high-carbohydrate meals (HCMs) on ischemic threshold and stress left ventricular function on placebo and after partial fatty acid inhibition by trimetazidine (TMZ). Ten patients (9 men, age 68 +/- 7 years) were allocated to placebo and TMZ (40 mg TID), both administered in the 24 hours preceding testing, according to a randomized double-blind study design. All patients underwent stress (treadmill exercise testing according to the Bruce protocol) echocardiography after fasting (8 hours) and after an HFM and HCM (2 hours) either on placebo or on TMZ. Time to 1-mm ST-segment depression (time to 1 mm) and stress wall motion score index (WMSI) were evaluated. An HFM did not affect exercise variables compared with fasting, whereas an HCM resulted in a reduction of the ischemic threshold (time to 1 mm from 402 +/- 141 to 292 +/- 123 seconds, P = .025). Compared with placebo, TMZ improved time to 1 mm after fasting, HFM, and HCM (432 +/- 153 vs 402 +/- 141, 439 +/- 118 vs 380 +/- 107, 377 +/- 123 vs 292 +/- 123, F(1,9) = 26.91, P = .0006). Compared with placebo, on TMZ, stress WMSI decreased from 1.55 +/- 0.25 to 1.29 +/- 0.14 after fasting, from 1.57 +/- 0.10 to 1.39 +/- 0.28 after HFM, and from 1.64 +/- 0.21 to 1.39 +/- 0.21 after HCM (F(1,9) = 37.04, P = .0002). Interestingly, stress WMSI on TMZ was never different from rest WMSI on placebo. In patients with coronary disease, exercise testing after an HCM results in more severe myocardial ischemia compared with that after an HFM. The observed beneficial effects of the partial fatty acid inhibitor TMZ seem to be unrelated to meal composition and are possibly caused by the better glucose use induced by the drug.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050571064

Download citation: RISBibTeXText

PMID: 16781225

DOI: 10.1016/j.ahj.2006.01.006


Related references

Correction of episodes of transitory myocardial ischemia with trimetazidine in patients with ischemic heart disease combined with type 2 diabetes mellitus. Kardiologiia 47(7): 22-25, 2007

Effect of trimetazidine on biological activity of neutrophils in patients with transient myocardial ischemia induced by exercise testing. Polski Merkuriusz Lekarski 9(50): 548-551, 2000

The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease. Cardiology Journal 15(4): 344-350, 2008

Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina.. Kardiologiia 44(9): 23-28, 2004

Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. International Journal of Nanomedicine 6: 1391-1398, 2011

Does the Nucleus Ambiguus-Vague Nerve Mediate Anti-myocardial Ischemic Effect of Electroacupuncture of "Neiguan" (PC 6)-"Jianshi" (PC 7) in Myocardial Ischemia Rats. Zhen Ci Yan Jiu 41(3): 189-196, 2016

Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia. European Journal of Pharmacology 503(1-3): 123-128, 2004

Ventricular arrhythmias in patients recovering from myocardial infarction: Do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence?. Clinical Cardiology 16(2): 109-114, 1993

Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy. American Journal of Cardiology 69(5): 449-452, 1992

Effects of trimetazidine on myocardial metabolism evaluated by PET-CT in patients with ischemic cardiomyopathy. Zhonghua Xinxueguanbing Zazhi 36(1): 36-39, 2008

Effects of trimetazidine on myocardial metabolism evaluated by PET-CT in patients with ischemic cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 36(1): 36-39, 2008

Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress. Vestnik Khirurgii Imeni I. I. Grekova 158(5): 34-37, 1999

Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study. American Journal of Cardiovascular Drugs 3(5): 361-369, 2003

Direct anti ischemia effect of trimetazidine during coronary angioplasty ptca. Circulation 82(4 Suppl. 3): III302, 1990

Myocardial, metabolic and endothelial effects of trimetazidine in diabetic patients with ischemic dilated cardiomyopathy. Journal of the American College of Cardiology 37(2 Suppl. A): 154A, 2001